Modern management of acute myocardial infarction is built on a clinical evidence base
drawn from many studies undertaken over the past three decades. The evolution in clinical …

Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …

Acute myocardial infarction is a common disease with serious consequences in mortality,
morbidity, and cost to the society. Coronary atherosclerosis plays a pivotal part as the …

Over the past five decades, management of acute ST-segment elevation myocardial
infarction (STEMI) has evolved substantially. Current treatment encompasses a systematic …

Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …

Large randomised trials have demonstrated that fibrinolytic therapy can reduce mortality in
patients with suspected acute myocardial infarction (AMI). The indications for, and …

Acute Myocardial Infarction | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Abstract Aims The DANish Acute Myocardial Infarction 2 (DANAMI-2) trial found that
interhospital transport to primary percutaneous coronary intervention (pPCI) was superior to …

Background International research for acute myocardial infarction lacks comparisons of
whole health systems. We assessed time trends for care and outcomes in Sweden and the …

Background: ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–
elevation myocardial infarction (NSTEMI) management has evolved considerably over the …